Molecular remissions after non-myeloablative allografting for chronic myelocytic leukemia (CML).

被引：0
|
作者：
McSweeney, P
Niederwieser, D
Shizuru, J
Radich, J
Molina, A
Hegenbart, U
Chauncey, T
Sandmaier, B
Wolff, D
Blume, K
Storb, R
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Univ Leipzig, Leipzig, Germany
[4] Stanford Univ, Stanford, CA 94305 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3135
引用
收藏
页码：710A / 710A
页数：1
相关论文
共 50 条
  • [21] SPLENECTOMY IN CHRONIC MYELOCYTIC LEUKEMIA (CML) AND RELATED STATES
    SOKAL, JE
    ELIAS, EG
    MITTELMAN, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1971, 12 (NMAR): : 10 - +
  • [22] PROLIFERATIVE RETINOPATHY IN CHRONIC MYELOCYTIC-LEUKEMIA (CML)
    HOERAUF, H
    BOPP, S
    LAQUA, H
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1994, 205 (04) : 226 - 230
  • [23] Cutaneous lesions and chronic myelocytic leukemia (CML) in progression
    Paydas, S
    ANNALS OF HEMATOLOGY, 2002, 81 (03) : 178 - 178
  • [24] Cutaneous lesions and chronic myelocytic leukemia (CML) in progression
    S. Paydas
    Annals of Hematology, 2002, 81 : 178 - 178
  • [25] Continuous molecular response after discontinuation of imatinib mesylate following relapse after non-myeloablative allogeneic stem cell transplantation for CML
    Zinke-Cerwenka, W
    Eibl, M
    Sill, H
    Höfler, G
    Staber, P
    Linkesch, W
    BONE MARROW TRANSPLANTATION, 2004, 33 : S348 - S348
  • [26] Molecular remission of chronic myelogenous leukemia (CML): Evidence for a graft-versus-leukemia (GVL) effect following non-myeloablative allogeneic peripheral blood stem cell transplant (PBSCT).
    Childs, R
    Epperson, D
    Bahceci, E
    Clave, E
    van Rhee, F
    Jayasekara, D
    Barrett, J
    BLOOD, 1998, 92 (10) : 341B - 341B
  • [27] Chronic kidney disease after non-myeloablative stem cell transplantation
    Kersting, S.
    Verdonck, L. F.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S81 - S81
  • [28] A non-myeloablative regimen with minimal non relapse mortality for allografting patients with Hodgkin's disease
    Kottaridis, P
    Milligan, D
    Chopra, R
    Craddock, C
    Mahendra, P
    Hunter, A
    Marsh, J
    Chakraverty, R
    Mills, A
    Kyriakou, C
    McKeag, N
    Hale, G
    Waldmann, H
    Linch, D
    Goldstone, A
    Mackinnon, S
    BONE MARROW TRANSPLANTATION, 2001, 27 : S66 - S66
  • [29] Non-myeloablative allogeneic stem cell transplantation in 154 patients (pts) with chronic myeloid leukaemia (CML)
    Benakli, Malek
    Hamladji, Rose-Marie
    Nacer, Redhouane Ahmed
    Talbi, Amina
    Mehdid, Farih
    Belhadj, Rachida
    Rahmoune, Nadia
    BLOOD, 2007, 110 (11) : 321B - 321B
  • [30] Non-myeloablative allografting for patients with myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML).
    Taussig, DC
    Cavenagh, JD
    Davies, AJ
    Oakervee, H
    Syndercombe-Court, D
    Kelsey, SM
    Barnett, MJ
    Rohatiner, A
    Lister, A
    BLOOD, 2002, 100 (11) : 409A - 410A
12345